Post-exposure prophylaxis for blood borne viral infections in healthcare workers

Postgraduate Medical Journal

Volumn 79, Issue 932, 2003, Pages 324-328

  Varghese, George M ^a   Abraham, O C ^a   Mathai, D ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRY; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEDICAL CARE; OCCUPATIONAL EXPOSURE; PROPHYLAXIS; REVIEW; SEROCONVERSION; VIRUS INFECTION; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; BLOOD-BORNE PATHOGENS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEALTH PERSONNEL; HEPATITIS B; HEPATITIS C; HUMANS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK FACTORS; VIRUS DISEASES;

EID: 0037668279     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.932.324     Document Type: Review

References (32)

1. Jagger J, Hunt EH, Brand-Elnaggar J, et al. Rates of needlestick injury caused by various devices in a university hospital. N Engl J Med 1988;319:284-8.
2. United Nations Programme on HIV/AIDS/World Health Organisation. The report on the global HIV/AIDS epidemic. Barcelona: UNAIDS, June 2002.
3. Sepkowitz KA. Occupationally acquired infections in health care workers. Part 2. Ann Intern Med 1996;125:917-28.
4. Lewis TL, Alter HJ, Chalmers TC, et al. A comparison of the frequency of hepatitis B antigen and antibody in hospital and non-hospital personnel. N Engl J Med 1973;289:647-51.
5. Gounden YP, Moodley J. Exposure to human immunodeficiency virus among healthcare workers in South Africa. Int J Gynaecol Obstet 2000;69:265-70.
6. Chogle NL, Chogle MN, Divatia JV, et al. Awareness of post-exposure prophylaxis guidelines against occupational exposure to HIV in a Mumbai hospital. Natl Med J India 2002;15:69-72
7. Anonymous. Needle stick transmission of HTLV-3 from a patient infected in Africa. Lancet 1984;ii:1376-7.
8. Bell DM. Occupational risk of HIV virus infection in heath care workers: an overview. Am J Med 1997;102(5B):9-15.
9. Ippolito G, Puro V, De Carli G. The Italian study group on occupational risk of HIV infection. The risk of occupational HIV infection in health care workers. Arch Intern Med 1993;153:1451.
10. Centers for Disease Control and Prevention Update. HIV virus infections in health care workers exposed to blood of infected patients. MMWR Morb Mortal Wkly Rep 1987;36:285.
11. Fahey BJ, Koziol DE, Banks SM, et al. Frequency of non-parenteral exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145-53.
12. Handerson DK. Post exposure prophylaxis for occupational exposures to hepatitis B, hepatitis C and HIV virus. Surg Clin North Am 1995;75:1175-87.
13. Centers for Disease Control and Prevention. Recommendation for prevention and control of HCV infection and HCV related chronic disease. MMWR Morb Mortal Wkly Rep 1998;47:1.
14. Simonsen L, Kane A, Lloyd J, et al. Unsafe injections in developing world and transmission of blood borne pathogens. Bull World Health Organ 1999;77:789-800.
15. Kane A, Lloyd J, Kane M. Transmission of hepatitis B, hepatitis C and HIV through unsafe injections in the developing world. Bull World Health Organ 1999;77:801-7.
16. Charles SM, Richard DP, Janine J. Risk to health care workers in developing countries. N Engl J Med 2001;345:538-41.
17. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-51.
18. Karon JM, Rosenberg PS, McQuillan G, et al. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276:126-31.
19. Alter MJ, Krusgon-Moran, Ninan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
20. Hamonj B. Underreporting of needle stick injuries in a university hospital. Am J Infect Control 1983;11:174-7.
21. Centers for Disease Control and Prevention. Public health service guidelines for management of HCW exposures to HIV and recommendations for control and prevention. MMWR Morb Mortal Wkly Rep 1998;47(RR-7):1.
22. Case-control study of HIV seroconversion in HCWs after percutaneous exposure to HIV infected blood. MMWR Morb Mortal Wkly Rep 1995;44:929.
23. Rogerr MF, Shaffer N. Reducing the risk of maternal infant transmission of HIV by attacking the virus. N Engl J Med 1999:341:441-3.
24. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal infant transmission of HIV type I with zidovudine treatment. N Engl J Med 1994;331:1173-80.
25. Manion DJ, Hirsch MS. Combination chemotherapy for HIV-1. Am J Med 1997;102(5B):76-80.
26. Lafeuillade A, Poggi C, Tamalet C, et al. Effects of a combination of zidovudine, didanosine and lamivudine on primary HIV type 1 infection. J Infect Dis 1997;175:1051-5.
27. Centers for Disease Control and Prevention Update. Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR Morb Mortal Wkly Rep 1996;45:468.
28. Centers for Disease Control and Prevention. Updated US Public Health Service Guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 2001;50:RR 11(June 29).
29. Centers for Disease Control and Prevention. Guidelines for prevention of transmission of HIV and HBV to health care and public safety workers. MMWR Morb Mortal Wkly Rep 1989;38:3-37.
30. Roome AJ, Walsh SJ, Cartter ML, et al. Hepatitis B, vaccine responsiveness in Connecticut to public safety personnel. JAMA 1993;270:2931-4.
31. Wood RC, Mac Donald KL, White KE. Risk factors for lack of detectable antibody following hepatitis B. Vacination of Minnesota health care workers. JAMA 1993;270:2935-9.
32. Centers for Disease Control and Prevention. Recommendations for protection against viral hepatitis. MMWR Morb Mortal Wkly Rep 1985;34:313-24, 329-35.